LI WILLIAM 4
4 · LEAP THERAPEUTICS, INC. · Filed Sep 2, 2022
Insider Transaction Report
Form 4
LI WILLIAM
Director
Transactions
- Award
Stock Option (Right to Buy)
2022-09-01+25,000→ 25,000 totalExercise: $1.43Exp: 2032-08-31→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]The Option was granted pursuant to Leap's 2022 Equity Incentive Plan and shall vest and become exercisable in a series of 4 quarterly installments until the Option is fully vested, with the first such quarterly installment vesting on the three-month anniversary of September 1, 2022, the Vesting Start Date.